Search

Metal–organic frameworks (MOFs) combined with sonodynamic therapy (SDT) have been introduced as a new and efficient treatment method. The critical advantage of SDT is its ability to penetrate deep tissues and concentrate energy on the tumor site to achieve a non-invasive or minimally invasive effect. Using a sonosensitizer to generate reactive oxygen species (ROS) under ultrasound is the primary SDT-related method of killing tumor cells. In the presence of a sonosensitizer, SDT exhibits a more lethal effect on tumors. The fast development of micro/nanotechnology has effectively improved the efficiency of SDT, and MOFs have been broadly evaluated in SDT due to their easy synthesis, easy surface functionalization, high porosity, and high biocompatibility. This article reviews the main mechanism of action of sonodynamic therapy in cancer treatment, and also reviews the applications of MOFs in recent years. The application of MOFs in sonodynamic therapy can effectively improve the targeting ability of SDT and the conversion ability of reactive oxygen species, thus improving their killing ability on cancer cells. This provides new ideas for the application of micro/nano particles in SDT and cancer therapy.

This paper reports an in situ measurement on the effects of a tunnel and its ventilation modes on the aerodynamic drag of a subway train with eight carriages during its routine operation. The train speed (V) varied continually from 0 to 22 m/s. Two modes of tunnel ventilation were examined, i.e., recirculation and free-cooling modes. The former mode is associated with pumping cooled air into the tunnel to provide extra cooling, while the latter is not. The friction coefficient Cf of the train surface was estimated using two hotwire probes mounted on the roof of the first and last carriages, respectively. The front- and rear-stagnation pressures (Pf and Pl) were measured using two pressure taps located at the center of the forward surface of the first carriage and the backward surface of the last carriage, respectively. It has been found that the presence of a tunnel significantly increases both Cf and Pf. For example, at V = 20.5 m/s, Cf and Pf were 30.2% and 24.5% higher, respectively, in the tunnel than their counterparts in open air. The tunnel ventilation mode also has remarkable effects on Cf. The recirculation mode resulted in 23.5% higher Cf than the free-cooling mode. On the other hand, the tunnel ventilation mode does not seem to have an appreciable effect on Pf. The physics behind these observations is also discussed.

Anthracycline is a mainstay of treatment for breast cancer patients because of its antitumor activity. However, anthracycline resistance is a critical barrier in treating breast cancer. Thus, it is of great importance to uncover the molecular mechanisms underlying anthracycline resistance in breast cancer. Herein, we integrated transcriptome data, genetic alterations data, and clinical data of The Cancer Genome Atlas (TCGA) to identify the molecular mechanisms involved in anthracycline resistance in breast cancer. Two hundred and four upregulated genes and 1376 downregulated genes were characterized between the anthracycline-sensitive and anthracycline-resistant groups. It was found that drug resistance-associated genes such as ABCB5, CYP1A1, and CYP4Z1 were significantly upregulated in the anthracycline-resistant group. The gene set enrichment analysis (GSEA) suggested that the P53 signaling pathway, DNA replication, cysteine, and methionine metabolism pathways were associated with anthracycline sensitivity. Somatic TP53 mutation was a common genetic abnormality observed in the anthracycline-sensitive group, while CDH1 mutation was presented in the anthracycline-resistant group. Immune infiltration patterns were extremely different between the anthracycline-sensitive and anthracycline-resistant groups. Immune-associated chemokines and cytokines, immune regulators, and human leukocyte antigen genes were significantly upregulated in the anthracycline-sensitive group. These results reveal potential molecular mechanisms associated with anthracycline resistance.

La0.8Sr0.2MnO3 (LSM) catalyst is prepared via a sol-gel method and modified via a typical silver mirror reaction. Silver ammonia solution is reduced in a polyvinylpyrrolidone (PVP)-containing solution to obtain silver nanoparticles and sodium dodecyl sulfate (SDS) is added as a surfactant. The microstructure and morphology of the LSM-Ag composite powder are characterized. According to the results, the Ag particles precipitate on the LSM surface in elemental form and the grain size is about one hundred nanometers. The analysis of electrocatalytic performance of LSM-Ag cathodes with different amounts of silver loading reveals that the number of electrons transferred during the oxygen reduction reaction (ORR) of the cathode with an Ag content of 14% by weight reached 3.9, which is very close to that of commercial Pt/C catalysts. Similarly, the maximum power density of the air battery made of LSM-14%Ag is 73 mW/cm2, which exceeds that of 63 mW/cm2, found for the LSM battery. Finally, increasing the amount of silver loading allows one to improve the electrochemical performance of LSM catalysts. The best effect is achieved when the Ag loading exceeds 14%.